CD8A and neoplasm: However, as we did not assessed their functionality, we currently don’t know if the infiltrated CD8 T-cells in our aggressive B-NHLs are immunologically exhausted or functional and could potentially act against the tumor cells when treated with immune-check point inhibitors (Wu et al.